NR2F1 and breast carcinoma: NR2F1-AS1 was shown to act as a ceRNA by sponging miR-338-3p, preventing it from downregulating IGF-1 [27]; the resulting increase in IGF-1 activated IGF1R in endothelial cells, increasing ERK signaling and breast cancer angiogenesis [27].